drugset / Trial / NCT00989209

Myofunctional Therapy in Facial Palsy

NCT00989209

RandomizedParallel-groupSingle-blindTreatment

Summary

Objective: Quantify the benefits of myofunctional therapy associated to botulinum toxin injection in patients with long standing facial unilateral palsy.

Timeline

Start
2005-01
Primary completion
2005-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic

Indications